AB Science Eulerpool Ziņas

AB Science Eulerpool News

AB Science Akciju Ziņas

AB Science tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās AB Science ziņas mēs apkopojam šeit.

• 26. septembris ·

  Yahoo
  AB Science provides an update on the microtubule program AB8939 and in particular the ability of AB8939 to generate response on MECOM rearrangement
• 23. septembris ·

  Yahoo
  AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis post ECTRIMS 2024
• 8. jūlijs ·

  Yahoo
  AB Science touts positive Phase II Covid-19 data for masitinib
• 8. jūlijs ·

  Yahoo
  AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19
• 28. jūnijs ·

  Yahoo
  AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
• 31. maijs ·

  Yahoo
  AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the application for conditional marketing authorization of masitinib in ALS
• 29. maijs ·

  Yahoo
  AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
• 15. maijs ·

  Yahoo
  AB Science reports its revenues for the year 2023 and provides an update on its activities
• 13. maijs ·

  Yahoo
  AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
• 7. maijs ·

  Yahoo
  AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient